Skip to main content

Search

Reset all filters
968 Result(s)
Sort by

Aiko Watabe

Aiko Watabe

Prioritizing development with Aiko Watabe
Practical Advice

Practical Advice

Practical advice for people with type 2 diabetes (T2D) at risk of heart disease
IPF treatment discussions

IPF treatment discussions

Listen to Steve Jones (a person living wih IPF) and Dr. Marlies Wijsenbeek (a leading pulmonologist) discuss the importance of treatment discussions in IPF
Professor Richeldi treatment initiation

Professor Richeldi treatment initiation

Leading pulmonologist Professor Richeldi discusses why early initiation of treatment in Idiopathic Pulmonary Fibrosis is important.
BULTAVO 3

BULTAVO 3

Indicated for bluetongue disease serotype 3 in sheep and cattle
Ryan Henri Rickards

Ryan Henri Rickards

Independent, authentic, bold - Ryan Henri Rickards’ career path
Patricia Rangel

Patricia Rangel

Patricia Rangel on transforming lives for generations
Cooperation with The Defeat-NCD Partnership

Cooperation with The Defeat-NCD Partnership

Together with The Defeat-NCD Partnership, Boehringer Ingelheim aims to address key access to healthcare issues related to non-communicable diseases.
L'Arte di Respirare IN IPF

L'Arte di Respirare IN IPF

Expert Prof. Richeldi discusses the link between Idiopathic Pulmonary Fibrosis (IPF) and Leonardo da Vinci and importance of taking action early.
Ann-Kathrin Koller

Ann-Kathrin Koller

Diverse, caring, collaborative - Ann-Kathrin Koller on Boehringer Ingelheim
Four Pillars Cancer Immunology

Four Pillars Cancer Immunology

Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation